Chancellor and colleagues used rats and mice in their experiments, but he believes they are ready to do the experiment on humans. However, because of the many unknowns about stem cell research, academic centers have been reluctant to finance expensive human trials, he says. Consequently, Chancellor and colleagues are hoping to find a biotechnology firm that will invest in the procedure. We don't perceive the need to do any more animal studies. And Chancellor believes the market for stem cell transplants to rebuild the urinary tract system may be huge.
Urinary incontinence is the last condition to come out of the closet.
All rights reserved. All rights reserved.